Insulinothérapie chez le diabétique de type 2 : insulines conventionnelles ou analogues ?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Annales D Endocrinologie

• Publication date

  2015-09-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/J.ANDO.2015.07.803
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.

  2008cited by this paper
• A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes

  2007cited by this paper
• Basal insulin therapy in type 2 diabetes.

  2005cited by this paper
• Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus.

  2005cited by this paper
• Lower within‐subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

  2005cited by this paper
• A Comparison of Bedtime Insulin Glargine with Bedtime Neutral Protamine Hagedorn Insulin in Patients with Type 2 Diabetes: Subgroup Analysis of Patients Taking Once-Daily Insulin in a Multicenter, Randomized, Parallel Group Study

  2004cited by this paper
• Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes.

  2004cited by this paper
• Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

  2002cited by this paper
• Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.

  2001cited by this paper
• Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.

  1999cited by this paper

• No citing papers are available for this paper.